|
|
|
|
|
Product Announcements
|
|
Strong Bonded Catalyst Substrates
Pollution Control Associates, Inc. (PCA) Benzophenone 3 -MAXGARD® 500 Syrgis Custom Catalysts and Initiators Catalytic Products International, Inc. Norox® Pulcat® AW Syrgis Norox® 750 - Liquid Organic Peroxide Syrgis Fast Turnaround on Replacement Catalysts Pollution Control Associates, Inc. (PCA) |
|
Report on Carcinogens, Twelfth Edition (2011) Table of... the accumulation of amyloid, an abnormal complex administration of an agent in a single dose material composed of protein and carbohydrate, in body |
|
|
The NIH Catalyst, January-February 2000 Much of our effort is focused on Vav, a guanine nucleotide exchange factor that is selectively expressed in hematopoietic cells. |
|
|
02nd week of 2009 patent applcation highlights... catalyzer comprising a support that has a plurality of cells and a purification layer that has an HC absorption layer and a three-way catalyst layer. |
|
|
36th week of 2009 patent applcation highlights... and demonstrating EP agonist activity that may be used to expand hematopoietic stem cell populations or to treat or prevent influenza, bone fracture, |
|
|
Robust Summaries & Test Plan; Ring Substituted Anilines... significant increases in and hematopoietic activity fetuses: 100 increased relative liver weights and hematopoietic activity Reference: Price, et al, |
|
|
Class 435: CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY (... . Mutation employing a chemical mutagenic agent . . By use of intercalating agent (e.g., acridine orange, etc.) |
|
|
Class 530: CHEMISTRY: NATURAL RESINS OR DERIVATIVES;... |
|
|
Biomedical Technologies - Technology Transfer Office New Drug Treatment for Large B-Cell Lymphomas or Other Hematopoietic Malignancies (SD2008-071) |
|
|
Best Poster MBI Poster Session Abstracts (Listed... Cis- platinum, a genotoxic agent, can be alternatively used as an antibiotic, and it was tested against the complete Escherichia coli knockout |
|
|
UCLA Patents called G2A, whose expression is regulated and function at the G2/M check-point to ensure properly controlled duplication of hematopoietic cells. |